Find Us On:
- Program
Learn about the program's unique curriculum, world-class faculty and convenient schedule. In just two years, you can earn your degree while still working full-time.
- Faculty and Staff
Program Staff
Richard Moss, Ph.D.
Senior Associate Dean for Basic Research, Biotechnology and Graduate Studies
Executive Director and Co-founder, M.S. in Biotechnology Program
ProfessorKurt Zimmerman, M.S.
Director, Industry Engagement, SMPH
Director, Master of Science in Biotechnology ProgramNatalie Betz, Ph.D.
Associate Director and Faculty Instructor, Master of Science in Biotechnology ProgramBryan Husk, M.A.
Assistant Director, Master of Science in Biotechnology ProgramMichele Smith, MS SCT(ASCP)
Program Manager, Master of Science in Biotechnology ProgramFaculty and Instructors
The Master of Science of Biotechnology Program brings together the expertise of the University of Wisconsin's world-class faculty, and the applied experience of the region's most successful biotechnology leaders from private industry.
Natalie Betz, Ph.D.
Associate Director and Faculty Instructor
Master of Science in BiotechnologyKarin Borgh, Ph.D.
Executive Director of BTCI
BioPharmaceutical Technology Center InstituteTom Burke, Ph.D.
Director of Genome Engineering
Cellular Dynamics International Inc.Russ Coff, Ph.D.
Associate Dean of Research,
Professor, Management & Human Resources
Wisconsin School of BusinessAbigail Davis
Senior Quality Assurance Manager
Promega CorporationHansi Dean, Ph.D.
Vice President and Head, Discovery Research
Takeda Pharmaceuticals USA, Inc.Ed Elder, Ph.D., R.Ph.
Director, Zeeh Pharmaceutical Experiment Station
UW-Madison, School of PharmacyMichael Falk, J.D., M.B.A.
General Counsel
Wisconsin Alumni Research FoundationScott Fulton, M.S.
Founder and CEO
Cellera, LLCFabio Gaertner, Ph.D.
Assistant Professor of Accounting & Information Systems
Wisconsin School of BusinessMartin Ganco, Ph.D.
Associate Professor, Management & Human Resources
Wisconsin School of BusinessHeather Gerard, M.S.
Intellectual Property Manager
Promega CorporationJennifer Gottwald, Ph.D.
Licensing Manager
Wisconsin Alumni Research FoundationDerek Hei, Ph.D.
Director, Waisman Biomanufacturing
Cellular Dynamics International Inc.Susan LaBelle, M.B.A.
Managing Director
Office of Corporate RelationsDave Lewis, Ph.D.
Chief Scientific Officer (former)
Arrowhead ResearchThomas Machleidt, Ph.D.
Senior Research Scientist
Promega CorporationTerri McDonnell, M.B.A.
Senior Program Manager
Promega CorporationEugene McNally, Ph.D.
Executive Director, Product Development and Manufacturing
Pharmaceutical Product Development, Inc. (PPD)Pilar Ossorio, Ph.D., J.D.
Professor of Law and Bioethics
University of Wisconsin Law SchoolHart Posen, Ph.D., M.B.A.
Associate Professor, Management & Human Resources
Wisconsin School of BusinessMarla Rybowiak
Director of Operations
The Employer GroupJay Schiestle, M.B.A.
Vice President, Operations and Diagnostics
Lucigen Corp.Richard Schifreen, Ph.D.
Accelerator Program Manager
Wisconsin Alumni Research FoundationChris Sebranek
Director Of Quality Assurance
LSNE Contract ManufacturingBen Seffrood M.B.A., M.S.
Head of Finance
Roche NimbleGenLaura Strong, Ph.D.
President and COO
Quintessence BiosciencesCharlie Trevor, Ph.D.
Professor, Management & Human Resources
Wisconsin School of BusinessCheryl Vickroy, M.B.A.
Director
Center for Technology CommercializationEric B. Vincent, Ph.D.
Global Product Manager
Promega CorporationMary Wang, M.A.
ESL Instructor
English as a Second Language, English DepartmentMary Westrick, Ph.D.
Vice President, US Phase I (retired)
QuintilesScott WildmanPh.D.
Computational Chemist
UW Carbone Cancer Center- Current Students
Essential Information
Program Resources
Commencement Information
- Alumni
The M.S. in Biotechnology program has over 300 alumni since its first graduates in 2004.
Each year the value of the alumni network strengthens as more students graduate and grow their careers.
Alumni by Graduating Class:
- Social Media
- Contact Us
Course Descriptions
- Year 1, Fall Semester
- Intellectual Property, Patents and Licensing
- Business Fundamentals for Biotechnology
- Molecular Technologies I: Diagnostic Testing
- Biotechnology Regulation and Ethics
- Year 1, Spring Semester
- Biotechnology Operations
- Molecular Technologies II: Biomanufacturing
- Project Management and Leadership
- Year 2, Fall Semester
- Early Drug Discovery
- Molecular Technologies III: Assay Development
- Business of Biotech: Commercialization Pathways
- Year 2, Spring Semester
- Business of Biotech: Sustaining Growth
- Advanced Biotech: Global Perspectives
Course Descriptions
Molecular Technologies III: Assay Development
Instructors:
- Karin Borgh, Ph.D.
- Natalie Betz, Ph.D.
This powerful exploration of drug-discovery topics and concepts puts students in the role of scientists researching an inhibitor of Src Protein Kinase as a new drug therapy.
Hands-on laboratory sessions cover state-of-the-art assays, methods and data analysis used in primary and advanced levels of drug screening.
You'll focus on detecting kinase activity as a model for a relevant drug target, evaluate the effect of two putative inhibitors identified from a compound library during an initial screen and assess how the identified inhibitors effects cytochrome P450 activity and cell viability.
You'll gain experience with basic cell culture techniques, stem cell biology, fluorescent microscopy and high content screening. And as you master course concepts and lab practices, you'll also hone your scientific communication skills with short papers and a detailed scientific protocol.
Here are some of the topics taught in this course:
Session Topics from Fall 2018
Session 1: Introduction to MTIII; Introduction to the Drug Discovery Process and Targets; Introduction to Kinase and P450 Enzymes and Assay Technologies; Thermo Fisher Drug Screening Service Laboratory Tour
Session 2: Introduction to Data Analysis; Kinase Assay Laboratory; Introduction to the Final Capstone Project; Business Concepts Refresher
Session 3: Cytochrome P450 Technology Laboratory and Introduction to Cell Culture and Cell-Based Assays
Session 4: Introduction to Fluorescent Microscopy, High Content Screening, and In Vivo Imaging; Basic Cell Culture Laboratory Activities
Session 5: Stem Cells: Introduction and Role in Drug Discovery
Session 6: Cell-Based Assay Laboratory and Introduction to CRISPR
Session 7: Final Presentations
Question about the degree?
Contact Bryan
Class of 2020 Schedule
Fall 2018 | Spring 2019
Fall 2019 | Spring 2020Class of 2021 Schedule
Fall 2019 | Spring 2020
Fall 2020 | Spring 2021Class of 2022 Schedule
Fall 2020 | Spring 2021
Fall 2021 | Spring 2022Download The Brochure
Prospective Students
Biotech at UW-Madison
Program Description
Experience
Curriculum
Course Descriptions
Program Calendar
Requirements
Admissions
Tuition & Financial Aid©2019 Board of Regents of the University of Wisconsin System
School of Medicine and Public Health
University of Wisconsin – Madison
- Faculty and Staff
Kim Hartz
